Drusus A Johnson, Mark P Funnell, Liam M Heaney, Thomas G Cable, Patrick C Wheeler, Stephen J Bailey, Tom Clifford, Lewis J James
Introduction: Cannabidiol (CBD) is a nonintoxicating phytocannabinoid used in clinical treatments and sold widely in consumer products. CBD products may be designed for sublingual or oral delivery, but it is unclear whether either is advantageous for CBD absorption. This study compared CBD pharmacokinetics after providing CBD oil as sublingual drops and within orally ingested gelatin capsules, at a dose relevant to consumer products. Materials and Methods: Eight males completed three conditions in a participant-blinded, randomized crossover design...
September 22, 2023: Cannabis and Cannabinoid Research
Florian Brandes, Annekathrin M Keiler, Benedikt Kirchner, Melanie Borrmann, Jean-Noël Billaud, Marlene Reithmair, Matthias Klein, Patrizia Campolongo, Detlef Thieme, Michael W Pfaffl, Gustav Schelling, Agnes S Meidert
Introduction: Endocannabinoids in COVID-19 have immunomodulatory and anti-inflammatory properties but the functional role and the regulation of endocannabinoid signaling in this pandemic disorder is controversial. To exercise their biologic function, endocannabinoids need to travel across the intercellular space and within the blood stream to reach their target cells. How the lipophilic endocannabinoids are transported in the vascular system and how these hydrophobic compounds cross cell membranes is still unclear...
September 14, 2023: Cannabis and Cannabinoid Research
Zongshuan Duan, Erin Kasson, Sabrina Ruchelli, Aishwarya Rajamahanty, River Williams, Priyanka Sridharan, Tanvi Sapra, Campbell Dopke, Alexandria Pannell, Sapna Nakshatri, Carla J Berg, Patricia A Cavazos-Rehg
Background: With more states legalizing recreational cannabis, examining cannabis retail and marketing is crucial, as it may influence consumers' perceptions and behaviors. Particularly understudied is online cannabis retail. Methods: In Spring 2022, coders collected and analyzed data regarding retailer characteristics, age verification, and marketing strategies (e.g., product availability, health-related content, promotions, website imagery) among 195 cannabis retail websites in five U.S. cities (Denver, Colorado; Seattle, Washington; Portland, Oregon; Las Vegas, Nevada; Los Angeles, California)...
September 12, 2023: Cannabis and Cannabinoid Research
Cianna J Piercey, Maggie Mataczynski, Vanessa T Stallsmith, Noah N Emery, Hollis C Karoly
Background: College student cannabis use has increased significantly in recent years, and individuals aged 18-25 are at elevated risk for development of cannabis use disorder (CUD). While weekly cannabis use frequency is a commonly used measure of cannabis consumption, there is increasing scientific interest in exploring more nuanced measures of cannabis use. Currently, limited research exists examining the clinical utility of cannabis quantity, within-day frequency, and potency variables. Methods: We used cross-sectional survey data from a sample of 617 undergraduate students in the state of Colorado...
September 12, 2023: Cannabis and Cannabinoid Research
Agostina B Marquez, Josefina Vicente, Eliana Castro, Daiana Vota, María S Rodríguez-Varela, Priscila A Lanza Castronuovo, Giselle M Fuentes, Alejandro R Parise, Leonardo Romorini, Diego E Alvarez, Carlos A Bueno, Cristina L Ramirez, Agustina Alaimo, Cybele C García
Introduction: Cannabidiol (CBD), the main non-psychoactive cannabinoid of the Cannabis sativa plant, is a powerful antioxidant compound that in recent years has increased interest due to causes effects in a wide range of biological functions. Zika virus (ZIKV) is a virus transmitted mainly by the Aedes aegypti mosquitoes, which causes neurological diseases, such as microcephaly and Guillain-Barre syndrome. Although the frequency of viral outbreaks has increased recently, no vaccinations or particular chemotherapeutic treatments are available for ZIKV infection...
September 8, 2023: Cannabis and Cannabinoid Research
Sitthiphon Bunman, Sombat Muengtaweepongsa, Dilok Piyayotai, Ratthaphol Charlermroj, Korawit Kanjana, Sudtida Kaew-Amdee, Manlika Makornwattana, Sanghyun Kim
Introduction: Cannabidiol (CBD), a phytocannabinoid isolated from cannabis plants, is an interesting candidate for studying its anti-inflammatory effects, especially in the pre-clinical and animal models. Its anti-inflammatory effects, such as reduction of edema and arthritis, have been demonstrated in animal models. However, topical CBD administration requires further evaluation of CBD dosage and efficacy in animal models and clinical settings. Methods: This in vivo study investigated the anti-inflammatory effects of topical CBD administration in an animal model...
September 5, 2023: Cannabis and Cannabinoid Research
Nilufar Foadi, Laura Dos Santos Teixeira, Franziska Fitzner, Thorben Dieck, Mathias Rhein, Matthias Karst
Background: In the course of the legalization of cannabis for therapeutic purposes in Germany, there has been growing interest in the medical use of cannabinoids. To date, the therapeutic potential of cannabinoids for the treatment of critically ill patients has not been explored. Objectives: This study aims to understand better whether and how frequently cannabinoids have been administered to critically ill patients in recent years. Study Design: Initially, a survey was conducted among physicians working in intensive care units (ICUs) at the Hannover Medical School...
September 4, 2023: Cannabis and Cannabinoid Research
Ehsan Moazen-Zadeh, Alexandra Chisholm, Keren Bachi, Yasmin L Hurd
Background: In this review, we provide an updated assessment of available evidence on the pharmacokinetics (PK) of CBD and explore the impact of different factors on PK outcomes. Materials and Methods: This systematic review and meta-regression analysis was preregistered (PROSPERO: CRD42021269857). We systematically searched Medline, Embase, PsycInfo, and Web of Science Core Collection up to November 19, 2022. Trials of CBD in healthy adults were included if they reported at least one of the PK parameters of interest, including Tmax , Cmax , AUC0-t , AUC0-inf , and T1/2 , in serum or plasma...
August 29, 2023: Cannabis and Cannabinoid Research
Fatima Bachir, Jalal El Oualidi, Ouafae Benkhnigue, Mohammed Fekhaoui
Background: Exploring the morphological traits of historical Cannabis populations from the Maghreb can provide invaluable information about the characteristics of the Maghreb Landrace Kif and contribute to the preservation of this vulnerable Cannabis resource. Aim: The purpose of the present study was to analyze the morphological characteristics of Cannabis specimens collected before worldwide introgressive hybridization and summarize the morphological traits of the Maghreb Landrace Kif. Discussion: Despite the limited number of specimens collected in the Maghreb, this study identified distinct types of Cannabis in the herbaria, including the Maghreb Landrace Kif, European hemp, and potentially East Asian hemp...
August 28, 2023: Cannabis and Cannabinoid Research
Ofir Livne, Kevin W Potter, Randy M Schuster, Jodi M Gilman
Introduction: Cannabis use to alleviate medical symptoms is increasing in middle-aged and older adults. Cognitive impairment associated with cannabis use may be especially detrimental to these understudied age groups. We hypothesized that among middle-aged and older adults who used cannabis for 12 months, frequent (≥3 days/week) compared with nonfrequent (≤2 days/week) use will be associated with cognitive impairment. Materials and Methods: We performed secondary analysis on data from a clinical trial of cannabis use for medical symptoms...
August 25, 2023: Cannabis and Cannabinoid Research
Aderbal S Aguiar
No abstract text is available yet for this article.
August 25, 2023: Cannabis and Cannabinoid Research
Alessandra Moraes Pedrosa, Thaís Teixeira Valério Caetano, Camila Moreno Lopes de Andrade, Mateus Moreira Bernardes, Bruna Cristina Alves, Vinícius Belo, Joaquim Maurício Duarte-Almeida, Vanessa C Stein
Background: With the expansion of the cannabis-derived product market, there is a growing need for seedling development to produce raw material for pharmaceutical applications and medicinal research. However, cannabis cultivation is illegal in many countries, and legal producers do not sell cannabis seeds in these countries. In Brazil, cannabis is still illegal, and the only way to obtain access to cannabis plants for research or as medicine is through importation, which is costly and requires authorization from the National Health Surveillance Agency (ANVISA), or from material seized by the police from drug trafficking...
August 23, 2023: Cannabis and Cannabinoid Research
Cara A Struble, Jacob T Borodovsky, Mohammad I Habib, Deborah S Hasin, Dvora Shmulewitz, Ofir Livne, Claire Walsh, Efrat Aharonovich, Alan J Budney
Background: Gender and sex can influence cannabis behaviors and consequences (Cannabis Use Disorder [CUD]). Research typically examines sex and gender independently. Gender analyses often exclude transgender and gender diverse (TGD) populations. The objectives of this study were to (a) replicate less frequent cannabis use among TGD young adults compared to cisgender counterparts (b) compare severity of CUD, and (c) examine the role of sex on cannabis outcomes. Method: Online survey participants between 18 and 34 ( N =1213) from the United States who reported past-week cannabis consumption provided information on cannabis practices and CUD from February to April 2022...
August 18, 2023: Cannabis and Cannabinoid Research
Baptiste Pasquier, Kristine Yaffe, Deborah A Levine, Jamal S Rana, Mark J Pletcher, Kali Tal, Stephen Sidney, Reto Auer, Julian Jakob
Background: Cannabis use may impair cognitive function (CF) differently in men and women, due to sex-specific differences in neurobiological mechanisms and environmental risk factors. Objective: Assess sex differences in the association between cumulative exposure to cannabis and cognitive performance in middle age. Methods: We studied participants from the Coronary Artery Risk Development in Young Adults (CARDIA) Study, including Black and White men and women 18-30 years old at baseline followed over 30 years...
August 18, 2023: Cannabis and Cannabinoid Research
Joris Guyon, Camille Paradis, Karine Titier, Coralie Braganca, Alexandre Peyre, Audrey Nardon, Amélie Daveluy, Mathieu Molimard, Magali Labadie, Nadège Castaing
No abstract text is available yet for this article.
August 16, 2023: Cannabis and Cannabinoid Research
Laura MacNair, Graham M L Eglit, Irina Mosesova, Marcel O Bonn-Miller, Erica N Peters
Introduction: A growing number of females report consuming cannabis products. There is a paucity of data on sex differences in safety and subjective effects after repeated use of varying oral doses of Δ9-tetrahydrocannabinol (THC; the primary psychoactive constituent of cannabis). Materials and Methods: Data were from two randomized, double-blind, placebo-controlled, multiple-dose, between-subject trials of two THC-containing oral cannabis products. Healthy adults received placebo, low-dose THC (∼2...
August 11, 2023: Cannabis and Cannabinoid Research
Abhinandan Banerjee, William Hosie, Ana Carolina Terso Ventura, Kasra Razmkhah, Joseph Bautista, Afeson Beyene, Justin Binder, John F Trant
Background: This article highlights the formulation of a solid Δ9 -tetrahydrocannabinol (THC)-loaded ingestible prepared from pure THC distillate. Methods: A THC-containing ethanol-assisted cannabinoid nanoemulsion (EACNE) was created using a solvent displacement technique. Subsequently, the EACNE was converted to a solid powdery material while still retaining its THC potency, a format uniquely suited for "microdosing" applications. Results: EACNE had an average lipid droplet size of ∼190 nm, with a polydispersity index of 0...
August 9, 2023: Cannabis and Cannabinoid Research
Toni C Spinella, Val Burdeyny, Alexandra Oprea, Tara S Perrot, Sean P Barrett
Background: Cannabidiol (CBD), a nonpsychoactive cannabinoid found in the cannabis plant, has gained interest for its purported stress- and anxiety-reducing effects. However, the mechanisms underlying these effects remain unclear. Our group previously found that CBD expectancy alone resulted in lower state anxiety (vs. CBD-free expectancy) among those who strongly believed it was helpful for such purposes, in addition to influencing physiological measures (i.e., heart rate variability). Aims: Using data collected as part of this previously published larger study, we aimed to explore the extent to which CBD expectancy alone impacts cortisol in the context of a laboratory stressor...
August 7, 2023: Cannabis and Cannabinoid Research
João Luís Q Simei, José Diogo R Souza, João Roberto Lisboa, Alline C Campos, Francisco S Guimarães, Antonio Zuardi, José Alexandre S Crippa
Background: The concept of an "entourage" effect in the cannabis and cannabinoids' field was first introduced in the late 1990s, during a period when most research on medical cannabinoids focused on the effects of isolated cannabinoids, such as cannabidiol and Δ9-tetrahydrocannabinol. Over the past decade, however, with the increased understanding of the endocannabinoid system, the discovery of other phytocannabinoids and their potential therapeutic uses, the term has gained widespread use in scientific reviews and marketing campaigns...
August 3, 2023: Cannabis and Cannabinoid Research
Valentina Lorenzetti, Eugene McTavish, Samantha Broyd, Hendrika van Hell, Eleni Ganella, Akhil Raja Kottaram, Camilla Beale, Jennifer Martin, Peter Galettis, Nadia Solowij, Lisa-Marie Greenwood
Introduction: Cannabis use is associated with brain functional changes in regions implicated in prominent neuroscientific theories of addiction. Emerging evidence suggests that cannabidiol (CBD) is neuroprotective and may reverse structural brain changes associated with prolonged heavy cannabis use. In this study, we examine how an ∼10-week exposure of CBD in cannabis users affected resting-state functional connectivity in brain regions functionally altered by cannabis use. Materials and Methods: Eighteen people who use cannabis took part in a ∼10 weeks open-label pragmatic trial of self-administered daily 200 mg CBD in capsules...
July 26, 2023: Cannabis and Cannabinoid Research
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.